Clinical studies investigating the use of leuprorelin for prostate cancer in Asia

BACKGROUND: Leuprorelin is a well-established treatment for prostate cancer (PCa); however, there is limited information on its use in Asian males. This review of English language publications between January 2000 and 2016 describes the outcomes of clinical trials on leuprorelin in Asian males with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Byung Ha, Horie, Shigeo, Chiong, Edmund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125360/
https://www.ncbi.nlm.nih.gov/pubmed/32257971
http://dx.doi.org/10.1016/j.prnil.2019.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125360/
https://www.ncbi.nlm.nih.gov/pubmed/32257971
http://dx.doi.org/10.1016/j.prnil.2019.06.001

Ejemplares similares